Jones Michael L
- SEC CIK
- 0001800060
No open-market purchases or sales filed in the past year.
Current role at each company
- BCRX Biocryst Pharmaceuticals IncExec. Director, Finance - PAOas of Dec 21, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Jones Michael L as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2022 (view filing) | Dec 15 | 4 days | Jones Michael LExec. Director, Finance - PAO | SSale | −445 | $10.90 | −$4.85K | −4.0%10.8K after | |
| Dec 2, 2022 (view filing) | Dec 1 | 1 day | Jones Michael LExec. Director, Finance - PAO | SSale | −8.60K | $13.01 | −$111.9K | −43.4%11.2K after | |
| Mar 3, 2022 (view filing) | Mar 1 | 2 days | Jones Michael LExec. Director, Finance - PAO | SSale | −2.30K | $17.20 | −$39.6K | −17.0%11.2K after |